Cefepime with solvent
1,0 г № 1
Pharmacotherapeutic group
Active ingredient
Pharmaceutical form
Powder for solution for injections
ATC code
J01DE01
RX/OTC
RX
Registration certificate
UA/13564/01/01
General properties
Pharmacotherapeutic group
Antimicrobials for systemic use. β-lactam antibiotics. fourth-generation cephalosporins.
Therapeutic indications
Infections which pathogens susceptible to cefepime.
Adults:
- septicemia;
- intra-abdominal infections, including peritonitis and biliary tract infections;
- skin infections and subcutaneous tissue;
- gynecological infections;
- respiratory tract infections including pneumonia, bronchitis;
- prevention of postoperative complications in intra-abdominal surgery;
- an empirical therapy of patients with neutropenic fever.
Children.
- pneumonia;
- urinary tract infections including pyelonephritis;
- skin and subcutaneous tissue infections ;
- septicemia;
- an empirical therapy of patients with neutropenic fever;
- bacterial meningitis.
Contraindications
Increased sensitivity to antibiotics of cephalosporin group or L-arginine, penicillin and other β-lactam & nbsp; antibiotics.
Pharmaceutical characteristics
Main physicochemical properties
The powder of white to light yellow in color.
Storage
Keep out of reach of children in original packaging at temperature not exceeding 25 оС.
Manufacturer
PJSC "Lekhim-Kharkiv".
Location
36, Severyna Pototskoho St., 61115 Kharkiv, Ukraine.
